✦ LIBER ✦

A multicenter study of supportive-expressive group therapy for women with BRCA1/BRCA2 mutations

✍ Scribed by Mary Jane Esplen; Jon Hunter; Molyn Leszcz; Ellen Warner; Steven Narod; Kelly Metcalfe; Gord Glendon; Kate Butler; Alexander Liede; Mary Anne Young; Stephanie Kieffer; Lisa DiProspero; Ellen Irwin; Jiahui Wong

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 129 KB
Volume: 101
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20661

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diabetes and breast cancer among women w

Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations

✍ Louise Bordeleau; Lorraine Lipscombe; Jan Lubinski; Parviz Ghadirian; William D. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 2 views

A supportive–expressive group interventi

A supportive–expressive group intervention for women with a family history of breast cancer: results of a phase II study

✍ Mary Jane Esplen; Brenda Toner; Jonathan Hunter; Gordon Glendon; Alexander Liede 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

Background: Evidence suggests that there are significant psychological and behavioural sequelae associated with having a family history of breast cancer (BC) which can interfere with comprehension of risk estimates. Purpose: The purpose of this study was to develop, standardize and do preliminary t

Appropriateness of breast-conserving tre

Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2 : A clinic-based series

✍ Mark Robson; Tiffany Svahn; Beryl McCormick; Patrick Borgen; Clifford A. Hudis; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

The histologic phenotypes of breast carc

The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations : A population-based study

✍ Jane E. Armes; A. J. Matthew Egan; Melissa C. Southey; Gillian S. Dite; Margaret 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

## BACKGROUND. Women with breast carcinoma diagnosed before age 40 years have a greater prevalence of germline BRCA1 and BRCA2 mutations than women with breast carcinoma diagnosed at older ages. Several recognizable histologic characteristics have been identified in breast carcinoma from studies o

Contribution of BRCA1 and BRCA2 germ-lin

Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: Results from a prospective population-based study in France

✍ Valerie Bonadona; Olga M. Sinilnikova; Sandrine Chopin; Antonis C. Antoniou; Her 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Abstract The prevalence of __BRCA1/2__ germ‐line mutations was assessed in a prospective population‐based series of early‐onset breast cancer (BC) patients in France, and the usefulness of a clinical assessment of hereditary BC risk, based on multiple criteria including pedigree structure, was e

Germ-line mutations in BRCA1 or BRCA2 in

Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A

✍ Patricia A. Mote; Jennifer A. Leary; Kelly A. Avery; Kerstin Sandelin; Georgia C 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

## Abstract The breast cancer susceptibility genes __BRCA1__ and __BRCA2__ are responsible for a large proportion of familial breast and ovarian cancer, yet little is known of how disruptions in the functions of the proteins these genes encode increased cancer risk preferentially in hormone‐depende